Temporal changes in vascular reactivity in early diabetes mellitus in rats: Role of changes in endothelial factors and in phosphodiesterase activity

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 2, 2009, Pages

  Abboud, K ^a   Bassila, J C ^a   Ghali Ghoul, R ^a   Sabra, R ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Endothelium; Vasoconstriction; Vasodilation

Indexed keywords

1,3 DIMETHYL 6 (2 PROPOXY 5 METHANESULFONYLAMIDOPHENYL)PYRAZOLO(3,4 D)PYRIMIDIN 4(5H) ONE; 1,3-DIMETHYL-6-(2-PROPOXY-5-METHANESULFONYLAMIDOPHENYL)PYRAZOLO(3,4-D)PYRIMIDIN-4(5H)-ONE; ACETYLCHOLINE; ALLOPURINOL; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 1; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 2; DRUG DERIVATIVE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; PHENYLEPHRINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE V; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ALLOPURINOL; ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 1; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 2; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; NITRIC OXIDE DONORS; PHENYLEPHRINE; PHOSPHORIC DIESTER HYDROLASES; RATS; RATS, SPRAGUE-DAWLEY; S-NITROSO-N-ACETYLPENICILLAMINE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 69449096561     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00102.2009     Document Type: Article

References (44)

1. Abiru T, Watanabe Y, Kamata K, Kasuya Y. Changes in endotheliumdependent relaxation and levels of cyclic nucleotides in the perfused mesenteric arterial bed from streptozotocin-induced diabetic rats. Life Sci 53: PL7-PL12, 1993.
2. Alabadi JA, Miranda FJ, Llorens S, Ruiz de Apodaca RF, Centeno JM, Alborch E. Diabetes potentiates acetylcholine-induced relaxation in rabbit renal arteries. Eur J Pharmacol 415: 225-232, 2001.
3. Bhardwaj R, Moore PK. Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J Pharm Pharamcol 40: 739-742, 1988.
4. Bolego C, Buccellati C, Tajnana R, Cetin I, Puglisi L, Folco G, Sala A. eNOS, COX-2, and prostacyclin production are impaired in endothelial cells from diabetes. Biochem Biophys Res Commun 339: 188-190, 2006.
5. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulindependent diabetes. J Clin Invest 90: 2548-2554, 1992.
6. Coste H, Grondin P. Characterization of a novel potent and specific inhibitor of type V phosphodiesterase. Biochem Pharmacol 50: 1577-1585, 1995.
7. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 15: 1983-1992, 2004.
8. Farkas K, Sarman B, Jermendy G, Somogyi A. Endothelial nitric oxide in diabetes mellitus: too much or not enough?. Diabetes Nutr Metab 13: 287-297, 2000.
9. Goldin E, Casadevall M, Mourelle M, Cirera I, Elizalde JI, Panés J, Casamitjana R, Guth P, Piqué JM, Terés J. Role of prostaglandins and nitric oxide in gastrointestinal hyperemia of diabetic rats. Am J Physiol Gastrointest Liver Physiol 270: G684-G690, 1996.
10. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105: 1656-1662, 2002.
11. Hopfner RL, McNeill JR, Gopalakrishnan. Plasma endothelin levels and vascular responses at different temporal stages of streptozotocin diabetes. Eur J Pharmacol 374: 221-227, 1999.
12. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 90: 21-28, 2002.
13. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin- dependent diabetes mellitus. Circulation 88: 2510-2516, 1993.
14. Kamata K, Miyata N, Kasuya Y. Impairment of endothelium dependent relaxation and changes in level of cyclic GMP in aorta from streptozotocin- induced diabetic rats. Br J Pharmacol 97: 614-618, 1989.
15. Keravis T, Tahseldar-Roumié R, Lugnier C. Assessment of phosphodiesterase isozyme contribution in cell and tissue extracts. Methods Mol Biol 307: 63-74, 2005.
16. Keravis TM, Wells JN, Hardman JG. Cyclic nucleotide phosphodiesterase activities from pig coronary arteries. Lack of interconvertibility of major forms. Biochim Biophys Acta 613: 116-1129, 1980.
17. Kobayashi T, Matsumoto T, Ooishi K, Kamata K. Differential expression of alpha2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats. Am J Physiol Heart Circ Physiol 287: H135-H143, 2004.
18. Koltai MZ, Hadhazy P, Posa I, Kocsis E, Winkler G, Rosen P, Pogatsa G. Characteristics of coronary endothelial dysfunction in experimental diabetes. Cardiovasc Res 34: 157-163, 1997.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
20. Matsumoto T, Kobayashi T, Kamata K. Alteration in EDHF type relaxation, and phosphodiesterase activity in mesenteric arteries from diabetic rats. Am J Physiol Heart Circ Physiol 285: H283-H291, 2003.
21. Mayhan WG, Simmons LK, Sharpe GM. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am J Physiol Heart Circ Physiol 260: H319-H326, 1991.
22. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW, Hayes JR. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulindependent) diabetes mellitus. Diabetologia 35: 771-776, 1992.
23. Meraji S, Jayakody L, Senarante MJP, Thomson ABR, Kappagoda T. Endothelium-dependent relaxation in aorta of BB rats. Diabetes 36: 978-981, 1987.
24. Miller MA, Morgan RJ, Thompson CS, Mikhailidis DP, Jeremy JY. Hydrolysis of cyclic guanosine monophosphate and cyclic adenosine monophosphate by the penis and aorta of the diabetic rat. Br J Urol 78: 252-256, 1996.
25. Murray P, Pitt B, Webb RC. Ramipril prevents hypersensitivity to phenylephrine in aorta from streptozotocin-induced diabetic rats. Diabetologia 37: 664-670, 1994.
26. Nagareddy PR, Xia Z, McNeill JH, MacLeod KM. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol 289: H2144-H2152, 2005.
27. Okon EB, Szado T, Laher I, McManus B. Augmented contractile response of vascular smooth muscle in a diabetic mouse model. J Vasc Res 40: 520-530, 2003.
28. Okumura M, Imanishi M, Yamashita T, Yamamura Y, Kim S, Iwao H, Tanaka S, Fujii S. Renal production of thromboxane and prostaglandins in a rat model of type 2 diabetes. Life Sci 66: 371-377, 1999.
29. Omer S, Shan J, Varma DR, Mulay S. Augmentation of diabetesassociated renal hyperfiltration and nitric oxide production by pregnancy in rats. J Endocrinol 161: 15-23, 1999.
30. Oyama Y, Kawasaki H, Hattori Y, Kanno M. Attenuation of endothelium- dependent relaxation in aorta from diabetic rats. Eur J Pharmacol 132: 75-78, 1986.
31. Pieper GM. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia 42: 204-213, 1999.
32. Ramanadham S, Lyness WH, Tenner TE. Alteration in aortic and tail artery reactivity to agonists after streptozotocin treatment. Can J Physiol Pharmacol 62: 418-423, 1984.
33. Rask-Madsen C, King GL. Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab 3: 46-56, 2007.
34. Shen B, Ye CL, Ye KH, Liu JJ. Mechanism underlying enhanced endothelium- dependent vasodilatation in thoracic aorta of early stage streptozotocininduced diabetic mice. Acta Pharmacol Sin 24: 422-428, 2003.
35. Sugimoto H, Shikata K, Matsuda M, Kushiro M, Hayashi Y, Hiragushi K, Wada J, Makino H. Increased expression of Ž. Endothelial cell nitric oxide synthase ecNOS in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 41: 1426-1434, 1998.
36. Sullivan S, Sparks HV. Diminished contractile response of aortas from diabetic rabbits. Am J Physiol Heart Circ Physiol 236: H301-H306, 1979.
37. Tahseldar-Roumieh R, Ghali-Ghoul R, Lugnier C, Sabra R. Effect of phosphodiesterase 5 inhibitor on alteration in vascular smooth muscle sensitivity and renal function in rats with liver cirrhosis. Am J Physiol Heart Circ Physiol 290: H481-H488, 2006.
38. Takahashi Y, Wakabayashi I. Depression of cyclooxygenase-2 induction in aortas of rats with type 1 and type 2 diabetes mellitus. Eur J Pharmacol 595: 114-118, 2008.
39. Taylor PD, Beryl B, Thomas CR, Poston L. Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenalineinduced contractility in mesenteric resistance arteries from streptozotocininduced diabetic rats. Br J Pharmacol 111: 35-41, 1994.
40. Taylor PD, Graves JE, Poston L. Selective impairment of acetylcholinemediated endothelium-dependent relaxation in isolated resistance arteries of the streptozotocin-induced diabetic rats. Clin Sci (Colch) 88: 519-524, 1995.
41. White RE, Carrier GO. Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin-diabetes. J Pharmacol Exp Ther 253: 1057-1062, 1990.
42. Wigg SJ, Tare M, Tonta MA, O'Brien RC, Meredith IT, Parkington HC. Comparison of effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery. Am J Physiol Heart Circ Physiol 281: H232-H240, 2001.
43. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulindependent diabetes mellitus. J Am Coll Cardiol 27: 567-574, 1996.
44. Zhu BH, Guan YY, Min J, He H. Contractile responses of diabetic rat aorta to phenylephrine at different stages of diabetic duration. Acta Pharmacol Sin 22: 445-449, 2001.